Rui‐Zhao Dong

588 total citations
7 papers, 140 citations indexed

About

Rui‐Zhao Dong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rui‐Zhao Dong has authored 7 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Rui‐Zhao Dong's work include RNA modifications and cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Rui‐Zhao Dong is often cited by papers focused on RNA modifications and cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Rui‐Zhao Dong collaborates with scholars based in China and Ethiopia. Rui‐Zhao Dong's co-authors include Jiabin Cai, Ai‐Wu Ke, Guo‐Ming Shi, Jia Fan, Jian Zhou, Xuan Yang, Pingting Gao, Hui‐Chuan Sun, Xinyu Zhang and Chuanyuan Wei and has published in prestigious journals such as Cancer Letters, Journal of Clinical Pathology and Cancer Science.

In The Last Decade

Rui‐Zhao Dong

7 papers receiving 138 citations

Peers

Rui‐Zhao Dong

MB

CR

PRM

ONCOL

EPIDE

Liangfang Shen China

Fionnuala A. McDyer United Kingdom

David T. Severson United Kingdom

Ajay Nair India

Qingxiang Yan United States

Donghua Geng China

Nora Balint‐Lahat Israel

Mai Q. Nguyen United States

Alexander Sartori Germany

Liangfang Shen China

Rui‐Zhao Dong

103 ×1.3

MB

36 ×0.8

CR

37 ×1.2

PRM

39 ×1.7

ONCOL

22 ×1.2

EPIDE

Citations per year, relative to Rui‐Zhao Dong Rui‐Zhao Dong (= 1×) peers Liangfang Shen

Countries citing papers authored by Rui‐Zhao Dong

Since Specialization

Citations

This map shows the geographic impact of Rui‐Zhao Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui‐Zhao Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui‐Zhao Dong more than expected).

Fields of papers citing papers by Rui‐Zhao Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui‐Zhao Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui‐Zhao Dong. The network helps show where Rui‐Zhao Dong may publish in the future.

Co-authorship network of co-authors of Rui‐Zhao Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Rui‐Zhao Dong. A scholar is included among the top collaborators of Rui‐Zhao Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui‐Zhao Dong. Rui‐Zhao Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Dong, Zhao‐Ru, Jiabin Cai, Guo‐Ming Shi, et al.. (2023). Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy. Cancer Letters. 564. 216186–216186. 10 indexed citations

2.

Dong, Rui‐Zhao, Xuan Yang, Xinyu Zhang, et al.. (2019). Predicting overall survival of patients with hepatocellular carcinoma using a three‐category method based on DNA methylation and machine learning. Journal of Cellular and Molecular Medicine. 23(5). 3369–3374. 25 indexed citations

3.

Liu, Lixin, Jia‐Cheng Lu, Haiying Zeng, et al.. (2019). Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma. Journal of Cancer. 10(25). 6199–6206. 15 indexed citations

4.

Yang, Xuan, Chuanyuan Wei, Rui‐Zhao Dong, et al.. (2019). Lymphoid‐specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression. Cancer Science. 110(7). 2133–2144. 28 indexed citations

5.

Wei, Chuanyuan, Weiyu Han, Xiaoqiang Chai, et al.. (2019). eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation.. PubMed. 9(5). 1079–1090. 18 indexed citations

6.

Gao, Pingting, Guangyu Ding, Xuan Yang, et al.. (2018). Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4.. PubMed. 8(6). 1040–1049. 22 indexed citations

7.

Kang, Qiang, Jiabin Cai, Rui‐Zhao Dong, et al.. (2017). Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro. Journal of Clinical Pathology. 70(8). 677–683. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact